The influence of two variants in the adenosine triphosphate-binding cassette transporter 1 gene on plasma lipids and carotid atherosclerosis

Metabolism: Clinical and Experimental

Volumn 57, Issue 10, 2008, Pages 1398-1404

  Sandhofer, Anton ^a   Iglseder, Bernhard ^b   Kaser, Susanne ^a   Morè, Elena ^b   Paulweber, Bernhard ^b   Patsch, Josef R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADENOSINE TRIPHOSPHATE BINDING CASSETTE TRANSPORTER 1 GENE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CIGARETTE SMOKING; GENE CASSETTE; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HUMAN; I883M GENE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; R219K GENE;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD PRESSURE; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DNA; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LIPIDS; MALE; MIDDLE AGED; PARTICLE SIZE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; SMOKING; TUNICA INTIMA; VARIATION (GENETICS);

EID: 51649129058     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.05.009     Document Type: Article

References (38)

1. Miller G.J., and Miller N.E. Plasma high-density lipoprotein concentration and development of ischaemic heart disease. Lancet 1 (1975) 16-19
2. Schaefer E.J., Lamon-Fava S., Ordovas J.M., Cohn S.D., Schaefer M.M., Castelli W.P., et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 35 (1994) 871-882
3. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104 (1999) R25-R31
4. Burris T.P., Eacho P.I., and Cao G. Genetic disorders associated with ATP binding cassette cholesterol transporters. Mol Genet Metab 77 (2002) 13-20
5. Wang J., Burnett J.R., Near S., Young K., Zinman B., Hanley A.J., et al. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 20 (2000) 1983-1989
6. Clee S.M., Zwinderman A.H., Engert J.C., Zwarts K.Y., Molhuizen H.O., Roomp K., et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103 (2001) 1198-1205
7. Lutucuta S., Ballantyne C.M., Elghannam H., Gotto Jr. A.M., and Marian A.J. Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 88 (2001) 969-973
8. Cenarro A., Artieda M., Castillo S., Mozas P., Reyes G., Tejedor D., et al. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. J Med Genet 40 (2003) 163-168
9. Zwarts K., Clee S., Zwinderman A., Engert J., Singaraja R., Loubser O., et al. ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 61 (2002) 115-125
10. Brunham L.R., Singaraja R.R., and Hayden M.R. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu Rev Nutr 26 (2006) 105-129
11. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., and Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114 (2004) 1343-1353
12. Law M.R., Morris J.K., and Wald N.J. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 315 (1997) 973-980
13. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43 (2004) 1731-1737
14. Ashen M.D., and Blumenthal R.S. Clinical practice. Low HDL cholesterol levels. N Engl J Med 353 (2005) 1252-1260
15. Sandhofer A., Kaser S., Ritsch A., Laimer M., Engl J., Paulweber B., et al. Cholesteryl ester transfer protein in metabolic syndrome. Obesity (Silver Spring) 14 (2006) 812-818
16. Kaser S., Sandhofer A., Foger B., Ebenbichler C.F., Igelseder B., Malaimare L., et al. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetologia 44 (2001) 1111-1117
17. Esterbauer H., Schneitler C., Oberkofler H., Ebenbichler C., Paulweber B., Sandhofer F., et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 28 (2001) 178-183
18. Sandhofer A., Iglseder B., Paulweber B., Ebenbichler C.F., and Patsch J.R. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest 37 (2007) 109-116
19. Rationale and design for the Asymptomatic Carotid Artery Plaque Study (ACAPS). The ACAPS Group. Control Clin Trials 13 (1992) 293-314
20. Schmidt H., Schmidt R., Niederkorn K., Horner S., Becsagh P., Reinhart B., et al. Beta-fibrinogen gene polymorphism (C148->T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Arterioscler Thromb Vasc Biol 18 (1998) 487-492
21. Wenham P.R., Price W.H., and Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 337 (1991) 1158-1159
22. Terwilliger J., and Ott J. Tukey multiple comparison procedure. Handbook of human genetic linkage (1994), Johns Hopkins University, Baltimore, MD 725-732
23. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson Jr. S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
24. Clee S.M., Kastelein J.J., van Dam M., Marcil M., Roomp K., Zwarts K.Y., et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106 (2000) 1263-1270
25. Sviridov D., and Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161 (2002) 245-254
26. Aiello R.J., Brees D., Bourassa P.A., Royer L., Lindsey S., Coskran T., et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22 (2002) 630-637
27. Haghpassand M., Bourassa P.A., Francone O.L., and Aiello R.J. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 108 (2001) 1315-1320
28. Evans D., and Beil F.U. The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia. J Mol Med 81 (2003) 264-270
29. Imamura H., Teshima K., Miyamoto N., and Shirota T. Cigarette smoking, high-density lipoprotein cholesterol subfractions, and lecithin:cholesterol acyltransferase in young women. Metabolism 51 (2002) 1313-1316
30. Mero N., Van Tol A., Scheek L.M., Van Gent T., Labeur C., Rosseneu M., et al. Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities. J Lipid Res 39 (1998) 1493-1502
31. Reaven G., and Tsao P.S. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease?. J Am Coll Cardiol 41 (2003) 1044-1047
32. Schmitz G., Kaminski W.E., Porsch-Ozcurumez M., Klucken J., Orso E., Bodzioch M., et al. ATP-binding cassette transporter A1 (ABCA1) in macrophages: a dual function in inflammation and lipid metabolism?. Pathobiology 67 (1999) 236-240
33. Flieger O., Engling A., Bucala R., Lue H., Nickel W., and Bernhagen J. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett 551 (2003) 78-86
34. Francone O.L., Royer L., Boucher G., Haghpassand M., Freeman A., Brees D., et al. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler Thromb Vasc Biol 25 (2005) 1198-1205
35. Van Eck M., Bos I.S., Kaminski W.E., Orso E., Rothe G., Twisk J., et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci U S A 23 (2002) 23
36. Harada T., Imai Y., Nojiri T., Morita H., Hayashi D., Maemura K., et al. A common Ile 823 Met variant of ATP-binding cassette transporter A1 gene (ABCA1) alters high density lipoprotein cholesterol level in Japanese population. Atherosclerosis 169 (2003) 105-112
37. Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J., and Hayden M.R. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23 (2003) 1322-1332
38. Brousseau M.E., Bodzioch M., Schaefer E.J., Goldkamp A.L., Kielar D., Probst M., et al. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis 154 (2001) 607-611